{
    "clinical_study": {
        "@rank": "137684", 
        "arm_group": {
            "arm_group_label": "HCC patients", 
            "description": "Hepatocellular carcinoma patients treated by radiofrequency ablation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the enumeration and function changes of regulatory\n      t cells in peripheral blood of hepatocellular carcinoma patients before and 1 week, 4 weeks\n      after ablation therapy."
        }, 
        "brief_title": "Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "Regulatory T cells\uff0cwhich are also called Treg cells\uff0cplay an important role in suppressing\n      anti-tumor immunity.Accumulated evidences indicate that Treg cells are elevated in\n      peripheral blood,however,there are also reports that decreased Treg cells are found in\n      hepatocellular patients.This study focuses on the changes of Treg cells ratio in peripheral\n      blood of hepatocellular carcinoma patients before and 1 week, 4 weeks after ablation ,also\n      its functional cytokines,such as TGF-\u03b2,IL-10,IFN-\u03b3,and inhibition function when co-cultured\n      with CD4+CD25-\u3001CD8+ cells. The investigators speculate that a decreased Treg ratio will be\n      found in patients who receive ablation therapy,and its function\n      cytokines,moreover,CD4+CD25-\u3001CD8+ cells' proliferation and function could be inhibited when\n      co-cultured with Treg cells."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  hepatocellular patients diagnosed through biopsy;or either dynamic imagine with a\n             diagnosis of hepatocellular carcinoma and alphafetoprotein\uff1e400\u03bcg/L\uff1bor two or more\n             dynamic imagine with a diagnosis of hepatocellular carcinoma\n\n          -  Child-Pugh A or B\n\n          -  well preserved renal and hematopoietic Function\n\n          -  receive ablation therapy through percutaneous radiofrequency ablation or microwave\n             ablation or ethanol injection ablation or any kind of combination of them.\n\n          -  achieve complete ablation accessed by contrast-enhanced CT\n\n        Exclusion Criteria:\n\n          -  incomplete ablation\n\n          -  remote metastasis\n\n          -  Child-Pugh C\n\n          -  general infection\n\n          -  autoimmune diseases\n\n          -  suffer from other tumors concurrently or in last five years\n\n          -  patients with immune deficit or infected by HIV\n\n          -  receiving glucocorticoid or other medicine inhibiting immune system"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "hepatocellular carcinoma patients underwent radiofrequency ablation therapy"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01668381", 
            "org_study_id": "2010B031600209"
        }, 
        "intervention": {
            "arm_group_label": "HCC patients", 
            "description": "the patients are prepared by local anesthesia and intravenous sedative.guided by the ultrasound,the antenna used for radiofrequency ablation ablation is placed in the tumor to destroy tumor tissues,the output power and duration are depended by the tumor volume and location.", 
            "intervention_name": "radiofrequency ablation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hepatocellular carcinoma", 
            "Catheter Ablation", 
            "T-Lymphocytes, Regulatory", 
            "IL-10", 
            "TGF-\u03b2", 
            "IFN-\u03b3"
        ], 
        "lastchanged_date": "February 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510080"
                }, 
                "name": "Sun Yat-Sen University,First Affiliated Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy", 
        "overall_official": [
            {
                "affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
                "last_name": "Ming Kuang, MD,PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
                "last_name": "Qing-qi Ren, Bachelor", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Science and Technology", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "changes of absolute counting of T cell subsets in peripheral blood of HCC patients before and 1,4 weeks after radiofrequency ablation therapy,such as CD3+,CD4+,CD8+,CD4+CD25+FOXP3+(Treg) cells.", 
                "measure": "variation of absolute counting of T cell subsets in peripheral blood of HCC patients before and 1,4 weeks after radiofrequency ablation therapy", 
                "safety_issue": "No", 
                "time_frame": "4 weeks post therapy"
            }, 
            {
                "description": "variation of serum IL-10,TGF-\u03b21,IFN-\u03b3 concentration of HCC patients before and 1,4 weeks after radiofrequency ablation therapy", 
                "measure": "variation of serum IL-10,TGF-\u03b21,IFN-\u03b3 concentration of HCC patients before and 1,4 weeks after radiofrequency ablation therapy", 
                "safety_issue": "No", 
                "time_frame": "4 weeks post therapy"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01668381"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "Ming Kuang,MD,PhD", 
            "investigator_title": "MD,PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "CD4+CD25+ T cells, derived from peripheral blood of HCC patients before and 1,4 weeks after radiofrequency ablation therapy,were co-cultured with CD4+CD25- or CD8+ T cells,which were stimulated by CD3/CD28 MACSiBead Particles.CD4+CD25- and CD8+ T cells proliferation changes were analysed to test CD4+CD25+ T cell suppression ability.", 
                "measure": "variation of proliferation suppression ability of CD4+CD25+ T cells of HCC patients before and 1,4 weeks after radiofrequency ablation therapy", 
                "safety_issue": "No", 
                "time_frame": "4 weeks post therapy"
            }, 
            {
                "description": "CD4+CD25+ T cells, derived from peripheral blood of HCC patients before and 1,4 weeks after radiofrequency ablation therapy,were co-cultured with CD4+CD25- or CD8+ T cells,which were stimulated by CD3/CD28 MACSiBead Particles.supernatant IFN-\u03b3 were analysed to test CD4+CD25+ T cell suppression ability.", 
                "measure": "variation of suppression ability of CD4+CD25+ T cells of HCC patients on cytokine secretion before and 1,4 weeks after radiofrequency ablation therapy", 
                "safety_issue": "No", 
                "time_frame": "4 weeks post therapy"
            }
        ], 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "collaborator": {
                "agency": "Guangdong Province, Department of  Science and Technology", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "First Affiliated Hospital, Sun Yat-Sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}